Last reviewed · How we verify
Anti-inflammatory drug
Anti-inflammatory drug is a Small molecule drug developed by Maastricht University Medical Center. It is currently in Phase 3 development for Inflammatory conditions (specific indication not disclosed).
An anti-inflammatory drug that reduces inflammatory pathways to treat inflammatory conditions.
An anti-inflammatory drug that reduces inflammatory pathways to treat inflammatory conditions. Used for Inflammatory conditions (specific indication not disclosed).
At a glance
| Generic name | Anti-inflammatory drug |
|---|---|
| Sponsor | Maastricht University Medical Center |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | Phase 3 |
Mechanism of action
Anti-inflammatory drugs work by inhibiting inflammatory mediators, cytokines, or signaling pathways that drive immune and inflammatory responses. Without a specific mechanism disclosed, this represents a broad class of agents used to suppress excessive inflammation across multiple therapeutic areas.
Approved indications
- Inflammatory conditions (specific indication not disclosed)
Common side effects
- Gastrointestinal disturbances
- Infection risk
- Hepatotoxicity
Key clinical trials
- A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis (PHASE3)
- A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies (PHASE3)
- Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI (PHASE1, PHASE2)
- Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting
- Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (PHASE1, PHASE2)
- In-Bedroom Renewed Air as Anti-inflammatory Adjuvant Therapy in Cancer Survivors (NA)
- Anti-Inflammatory Effects of Pecan Nut Oil Supplementation in Adults With Overweight: A Randomized Controlled Parallel-Group Clinical Trial (NA)
- PBMC as Biomarkers of Diabetic Cardiomyopathy
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Anti-inflammatory drug CI brief — competitive landscape report
- Anti-inflammatory drug updates RSS · CI watch RSS
- Maastricht University Medical Center portfolio CI
Frequently asked questions about Anti-inflammatory drug
What is Anti-inflammatory drug?
How does Anti-inflammatory drug work?
What is Anti-inflammatory drug used for?
Who makes Anti-inflammatory drug?
What development phase is Anti-inflammatory drug in?
What are the side effects of Anti-inflammatory drug?
Related
- Manufacturer: Maastricht University Medical Center — full pipeline
- Therapeutic area: All drugs in Immunology
- Indication: Drugs for Inflammatory conditions (specific indication not disclosed)
- Compare: Anti-inflammatory drug vs similar drugs
- Pricing: Anti-inflammatory drug cost, discount & access